# Lilly plans $2.5B injectable manufacturing site in Alzey, Germany

Eli Lilly announced plans to construct a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Germany, for injectable products. The site is expected to be operational beginning in 2027 and will employ up to 1,000 workers.

- Type: New facility
- Announced: 2023-11-17
- Where: Alzey, Rhineland-Palatinate, Germany
- Value: $2.50B
- Jobs: 1,000
- Starts operating: 2027
- Status: announced
- Products: injectable medicines, diabetes and obesity portfolio
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eli Lilly and Company](https://endata.com/companies/16522.md)

## Sources

- [nasdaq.com](https://www.nasdaq.com/press-release/lilly-to-expand-injectable-manufacturing-capacity-with-planned-$2.5-billion-site-in), 2023-11-17: "Every investment into our manufacturing capacity around the world is a renewed commitment to patients today – and to those who may need our medicines tomorrow."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.